Hanjia DI(300746)
Search documents
11月24日晚间重要公告一览
Xi Niu Cai Jing· 2025-11-24 10:21
Group 1 - Huafeng Co., Ltd. announced a stock suspension due to a potential change in control after signing a share transfer intention agreement [1] - Keshida plans to reduce its shareholding by up to 424,000 shares, representing 0.07% of its total share capital [1] - Jinqilin intends to distribute a cash dividend of 0.10 yuan per share, totaling 19.61 million yuan [1] Group 2 - Rejingshi Biotech has repurchased 904,100 shares, accounting for 0.98% of its total share capital, with a total expenditure of 150 million yuan [2] - Yishitong has repurchased 1,236,500 shares, representing 0.619% of its total share capital, with a total expenditure of approximately 33.49 million yuan [2] Group 3 - Hanjia Design announced the release of a detention on its subsidiary's chairman, allowing him to resume duties [4] - Qingmu Technology plans to acquire 65.83% of Vitalis Pharma AS for 300 million Norwegian Krone (approximately 212 million yuan) [4] - Anda Intelligent's shareholder plans to reduce its stake by up to 2.74% [4] Group 4 - Wansheng Intelligent is a candidate for a project with a pre-bid amount of approximately 42.99 million yuan, representing 4.56% of its audited revenue for 2024 [4] - Yipin Hong received a drug registration certificate for a medication used to treat Alzheimer's symptoms [4] Group 5 - *ST Sansheng received a total of 254 million yuan from restructuring investors [4] - Haichuang Pharmaceutical received approval for clinical trials of HP518 tablets for advanced prostate cancer treatment [4] Group 6 - Ningbo Huaxiang's subsidiary plans to invest 5 million yuan in a venture capital fund focusing on intelligent industries [4] - Petty Co. plans to repurchase shares worth 50 to 70 million yuan [4] Group 7 - Tongji Technology's subsidiary won a construction project with a bid price of 866 million yuan [4] - Prolo Pharmaceutical received a drug registration certificate for a generic drug [4] Group 8 - Jingyan Technology plans to use up to 1.6 billion yuan of idle funds for financial management [4] - Furan De received government subsidies totaling 34.65 million yuan [4] Group 9 - David Medical's subsidiary's medical device registration has been accepted [4] - Jusaylong plans to increase its subsidiary's capital by 170 million yuan through debt-to-equity conversion [4] Group 10 - Heng Rui Pharmaceutical's application for a drug license has been accepted by the National Medical Products Administration [4] - Lege Co. plans to increase its stake in the company by 40 to 80 million yuan [4] Group 11 - New Beiyang's subsidiary won a project with the Bank of Communications [4] - Jiangxi Changyun plans to publicly transfer land use rights and buildings with a starting price of 7.79 million yuan [4] Group 12 - Shenqi Pharmaceutical's subsidiary has paid approximately 16.67 million yuan in tax and penalties [4] - Panjiang Co. plans to invest 1.334 billion yuan in a power plant project [4] Group 13 - Fashilong's vice president resigned for personal reasons [4] - Chunxue Food received government subsidies of 3.79 million yuan [4] Group 14 - China Galaxy completed the repayment of a short-term financing bond totaling 3.025 billion yuan [4] - Jiuzhou Pharmaceutical received approval for a chemical raw material drug [4] Group 15 - Longqi Technology's subsidiary plans to invest 30 million yuan in a venture capital fund [4]
工程咨询服务板块11月24日涨5.04%,招标股份领涨,主力资金净流入4.18亿元
Zheng Xing Xing Ye Ri Bao· 2025-11-24 09:12
Core Insights - The engineering consulting services sector experienced a significant increase of 5.04% on November 24, with Zhaobiao Co. leading the gains [1] - The Shanghai Composite Index closed at 3836.77, up 0.05%, while the Shenzhen Component Index closed at 12585.08, up 0.37% [1] Stock Performance - Zhaobiao Co. (301136) saw a closing price of 16.32, with a remarkable increase of 20.00% and a trading volume of 197,700 shares, amounting to a transaction value of 315 million yuan [1] - Shanshui Bide (300844) closed at 42.40, up 15.41%, with a trading volume of 50,700 shares [1] - Qidi Design (300500) closed at 16.84, up 12.42%, with a trading volume of 348,200 shares [1] - Huajian Group (600629) closed at 21.67, up 10.00%, with a trading volume of 580,600 shares [1] - Other notable performers include Zhongda An (300635) with an 8.19% increase and Sujiao Ke (300284) with a 6.82% increase [1] Capital Flow - The engineering consulting services sector saw a net inflow of 418 million yuan from institutional investors, while retail investors experienced a net outflow of 95.14 million yuan [2] - The main capital inflow was concentrated in Huajian Group, which had a net inflow of 29.1 million yuan from institutional investors [3] - Zhaobiao Co. also attracted significant institutional interest, with a net inflow of 133 million yuan [3]
汉嘉设计(300746.SZ):控股子公司董事长解除留置
Ge Long Hui A P P· 2025-11-24 00:57
Core Viewpoint - The announcement details the investigation and subsequent release of the chairman of a subsidiary, indicating a resolution to the situation and the return to normal operations for the company [1] Group 1: Company Announcement - The company disclosed on November 17, 2025, that the chairman of its subsidiary, Suzhou Futai Information Technology Co., Ltd., was placed under investigation by the Suzhou Gusu District Supervisory Committee [1] - On November 23, 2025, the company received notification that the supervisory committee had issued a "Notice of Lifting Detention," allowing the chairman to resume his duties [1] - The company and its subsidiaries are currently operating normally following the resolution of the chairman's situation [1]
汉嘉设计控股子公司董事长沈刚解除留置
Zhi Tong Cai Jing· 2025-11-24 00:20
Core Viewpoint - HanJia Design (300746.SZ) announced that its subsidiary, Futai Technology, has received a notice from the Suzhou Gusu District Supervisory Committee, which has lifted the detention measures against Mr. Shen Gang, allowing him to resume his duties [1] Group 1 - The supervisory committee's decision indicates a positive development for the company, as it can now operate normally with Mr. Shen Gang back in his role [1] - The company's production and operational status remains normal following this announcement [1]
汉嘉设计(300746.SZ)控股子公司董事长沈刚解除留置
智通财经网· 2025-11-24 00:18
Core Points - Hanji Design (300746.SZ) announced that its subsidiary, Futai Technology, received a notice from the Suzhou Gusu District Supervisory Committee regarding the lifting of detention measures against Mr. Shen Gang [1] - Mr. Shen Gang is now able to resume his duties, and the company's production and operational activities are normal [1] Summary by Category - **Company Update** - Hanji Design's subsidiary, Futai Technology, has had the detention measures against Mr. Shen Gang lifted, allowing him to return to work [1] - The operational status of the company and its subsidiaries remains normal following this development [1]
汉嘉设计:控股子公司董事长沈刚解除留置
Zheng Quan Shi Bao Wang· 2025-11-24 00:12
Core Viewpoint - HanJia Design (300746) announced that its subsidiary, Futai Technology, has had the detention measures against its chairman, Shen Gang, lifted by the Suzhou Gusu District Supervisory Committee, allowing him to resume normal duties [1] Company Summary - On November 23, HanJia Design received notification from its subsidiary Futai Technology regarding the lifting of detention measures against its chairman [1] - Shen Gang is now able to perform his duties normally, indicating a return to regular operations for the company and its subsidiaries [1] - The production and operational status of the company and its subsidiaries remain normal following this development [1]
汉嘉设计(300746) - 关于公司控股子公司董事长解除留置的公告
2025-11-24 00:02
证券代码:300746 证券简称:汉嘉设计 公告编号:2025-090 汉嘉设计集团股份有限公司 2025 年 11 月 23 日,公司收到伏泰科技的通知,其收到苏州市姑苏区监察 委员会签发的《解除留置通知书》,苏州市姑苏区监察委员会已解除对沈刚先生 的留置措施。目前沈刚先生已能正常履职,公司及下属公司生产经营情况正常。 公司指定的信息披露媒体为《证券时报》《上海证券报》《中国证券报》《证 券日报》和巨潮资讯网(www.cninfo.com.cn),公司发布的信息均以在上述指定媒 体刊登的信息为准。敬请广大投资者理性投资,注意投资风险。 特此公告。 汉嘉设计集团股份有限公司董事会 关于公司控股子公司董事长解除留置的公告 本公司及全体董事保证本公告内容真实、准确和完整,没有虚假记载、误导 性陈述或者重大遗漏。 汉嘉设计集团股份有限公司(以下简称"公司")于 2025 年 11 月 17 日披露 了《关于公司控股子公司董事长被留置的公告》(公告编号:2025-087),公司控 股子公司苏州市伏泰信息科技股份有限公司(以下简称"伏泰科技")董事长、苏 州泰联智信投资管理合伙企业(有限合伙)实控人之一沈刚先生被苏州市 ...
汉嘉设计:关于全资子公司完成注销登记的公告
Zheng Quan Ri Bao Zhi Sheng· 2025-11-21 15:13
Core Viewpoint - The company has announced the decision to dissolve four wholly-owned subsidiaries, indicating a strategic shift in its operational structure [1] Group 1: Company Actions - The company will hold the 16th meeting of its sixth board of directors on December 24, 2024, to review the proposal for the dissolution of its subsidiaries [1] - The subsidiaries being dissolved include Jiangsu Hanjia Architectural Design Institute, Beijing Hanjia Architectural Design Institute, Xiamen Hanjia Architectural Design Institute, and Shanghai Hanjia Architectural Design Institute [1] - The company has received a registration notice from the Nanjing Market Supervision Administration, approving the dissolution of Jiangsu Hanjia [1] - As of the date of the announcement, the deregistration procedures for Jiangsu Hanjia have been completed [1]
汉嘉设计(300746) - 关于全资子公司完成注销登记的公告
2025-11-21 09:52
汉嘉设计集团股份有限公司(以下简称"公司")于 2024 年 12 月 24 日召开 第六届董事会第十六次会议,审议通过了《关于注销全资子公司的议案》。同意 公司注销全资子公司江苏汉嘉建筑设计院有限公司(以下简称"江苏汉嘉")、北京 汉嘉建筑设计院有限公司(以下简称"北京汉嘉")、厦门汉嘉建筑设计有限公司(以 下简称"厦门汉嘉")、上海汉嘉建筑设计有限公司(以下简称"上海汉嘉")等四家全 资子公司。具体内容详见公司在中国证监会指定创业板信息披露媒体巨潮资讯网 (www.cninfo.com.cn)发布的相关公告(公告编号:2024-064)。 近日,公司收到南京市市场监督管理局出具的《登记通知书》,准予江苏汉 嘉注销登记。截至本公告披露日,江苏汉嘉的注销登记手续已办理完毕。 证券代码:300746 证券简称:汉嘉设计 公告编号:2025-089 汉嘉设计集团股份有限公司 关于全资子公司完成注销登记的公告 本公司及全体董事保证本公告内容真实、准确和完整,没有虚假记载、误导 性陈述或者重大遗漏。 本次注销完成后,江苏汉嘉将不再纳入公司合并财务报表范围,公司在前述 子公司经营区域的业务仍由江苏分公司负责,不会对公司 ...
11月18日晚间重要公告一览
Xi Niu Cai Jing· 2025-11-18 10:20
Group 1 - Shengxin Lithium Energy signed a framework agreement with Huayou Cobalt for the procurement of 221,400 tons of lithium salt products over five years [1] - Wehua New Materials' subsidiary plans to acquire 70% of He Yutai for 154 million yuan [1] - Xiamen Tungsten plans to invest 600 million yuan to establish a wholly-owned subsidiary for a project with an annual production capacity of 50,000 tons of high-performance battery materials [1][2] Group 2 - *ST Songfa's subsidiary signed a shipbuilding contract worth approximately 200-300 million USD for two VLCCs [3] - Hailianxun's stock will resume trading on November 19 after the end of the acquisition request period [5] - Yunnan Energy Investment obtained the development rights for a 25,000 kW wind power project [7] Group 3 - China Resources Double Crane's subsidiary received a drug registration certificate for Oxcarbazepine tablets [8] - Jincheng Pharmaceutical's subsidiary received a CEP certificate for glutathione raw materials [9] - Jinkong Electric plans to transfer 51% of Tongying Thermal Power to an affiliate for 266 million yuan [9] Group 4 - Clean Technology's subsidiary won a bid for a waste incineration power generation project in Thailand with a total investment of up to 4.27 million USD [12] - Tonglian Precision's shareholders set the transfer price for shares at 43.67 yuan each [13] - Hu Nong Commercial Bank's executives collectively purchased 259,100 shares of the company [13] Group 5 - Huatai Medical's subsidiary obtained a medical device registration certificate for polyethylene embolization microspheres [13] - Fosun Pharma's subsidiary's drug registration application was accepted by the National Medical Products Administration [13] - Xianhui Technology signed contracts worth 796 million yuan with multiple subsidiaries of CATL [15] Group 6 - Ningbo Fangzheng signed a strategic cooperation agreement with Huaxiang Qiyuan for the development of various robotic technologies [15] - Ruida Futures' vice president resigned for personal reasons [16] - Samsung Medical is expected to win contracts worth approximately 125 million yuan from the State Grid [17] Group 7 - Tianjin Pharmaceutical's injectable methylprednisolone sodium succinate received registration from Panama's Ministry of Health [19] - Yaxing Anchor Chain plans to invest up to 300 million yuan in a project for deep-sea floating equipment [20] - Zejing Pharmaceutical's clinical trial for ZG006 was approved by the National Medical Products Administration [21] Group 8 - Weiye Co., Ltd. won a bid for a project worth approximately 2.086 billion yuan [23] - Ruimao Tong plans to sell 8.5794 million repurchased shares [25] - Guangge Technology's shareholders plan to reduce their holdings by up to 3.99% [26] Group 9 - Hongsheng Development signed a debt restructuring contract for a total of 2 billion yuan [27][28] - Yatai Co., Ltd. plans to reduce its holdings by up to 1% [30] - Dexin Technology's shareholder plans to reduce its holdings by up to 1% [31] Group 10 - Yaji International's shareholder plans to reduce its holdings by up to 1% [33] - Shenzhen New Star's subsidiary received approval for trial production of a boron trifluoride project [35] - Shengyi Electronics plans to raise up to 2.6 billion yuan through a private placement [36]